Ashoo Gupta
Equibles does not estimate personal net worth.
Get an email with a short summary when 4D Molecular Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get FDMT alertsAbout Ashoo Gupta
Ashoo Gupta is recorded as CFO at 4D Molecular Therapeutics, Inc. (FDMT) since September 30, 2025. 4D Molecular Therapeutics, Inc. reported in an 8-K filed October 2, 2025 that Ashoo Gupta was appointed Principal Financial Officer and Principal Accounting Officer, effective September 30, 2025. 4D Molecular Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at 4D Molecular Therapeutics, Inc. includes David Kirn (CEO and Board Member), David Kirn, M.D. (CEO), Kristian Humer (CFO and Chief Accounting Officer) and 7 others.
“On September 30, 2025, the Board of Directors (the "Board") of 4D Molecular Therapeutics, Inc. (the "Company") appointed Ashoo Gupta as Principal Financial Officer and Principal Accounting Officer of the Company, effective immediately.”
Affiliation history
-
Current
2025-09-30–present
Company network
Leadership on record at 4D Molecular Therapeutics, Inc.
- David Kirn CEO, Board Member
- David Kirn, M.D. CEO
- Kristian Humer CFO, Chief Accounting Officer
- Uneek Mehra CFO, Chief Accounting Officer
- Fred Kamal COO
- Charles Theuer Board Member
- Glenn Sblendorio Board Member
- Jacob Chacko Board Member
- John F. Milligan Board Member
- Nancy Miller-Rich Board Member